- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of RNA Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of RNA Drugsmarket, defines the market attractiveness level of RNA Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of RNA Drugs industry, describes the types of RNA Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global RNA Drugs market and the development prospects and opportunities of RNA Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global RNA Drugs market in Chapter 13.
By Player:
Abbott Laboratories
Benitec Biopharma
Sanofi-Aventis
Tekmira
Calimmune Inc
Gradalis
Arrowhead Pharmaceuticals
Silenseed
Silence Therapeutics
Senesco
Roche
RXi
Alnylam Pharmaceuticals
Dicerna
Quark
Pfizer
By Type:
siRNA
ASO
miRNA
Nucleic Acid Aptamers
By End-User:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 RNA Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 RNA Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 RNA Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 RNA Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise RNA Drugs Market Analysis and Outlook to 2022
-
7.1 Global RNA Drugs Consumption (2017-2022)
-
7.2 United States RNA Drugs Consumption (2017-2022)
-
7.3 Europe RNA Drugs Consumption (2017-2022)
-
7.4 China RNA Drugs Consumption (2017-2022)
-
7.5 Japan RNA Drugs Consumption (2017-2022)
-
7.6 India RNA Drugs Consumption (2017-2022)
-
7.7 South Korea RNA Drugs Consumption (2017-2022)
8 Region and Country-wise RNA Drugs Market Analysis and Outlook to 2028
-
8.1 Global RNA Drugs Consumption Forecast (2022-2028)
-
8.2 United States RNA Drugs Consumption Forecast (2022-2028)
-
8.3 Europe RNA Drugs Consumption Forecast (2022-2028)
-
8.4 China RNA Drugs Consumption Forecast (2022-2028)
-
8.5 Japan RNA Drugs Consumption Forecast (2022-2028)
-
8.6 India RNA Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea RNA Drugs Consumption Forecast (2022-2028)
9 Global RNA Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global RNA Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global siRNA Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ASO Consumption and Growth Rate (2017-2022)
-
9.1.3 Global miRNA Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Nucleic Acid Aptamers Consumption and Growth Rate (2017-2022)
-
9.2 Global RNA Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global RNA Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global RNA Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global siRNA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global ASO Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global miRNA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Nucleic Acid Aptamers Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global RNA Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global RNA Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global RNA Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global RNA Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 RNA Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global RNA Drugs Market Competitive Analysis
-
14.1 Abbott Laboratories
-
14.1.1 Abbott Laboratories Company Details
-
14.1.2 Abbott Laboratories RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Abbott Laboratories RNA Drugs Product and Service
-
14.2 Benitec Biopharma
-
14.2.1 Benitec Biopharma Company Details
-
14.2.2 Benitec Biopharma RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Benitec Biopharma RNA Drugs Product and Service
-
14.3 Sanofi-Aventis
-
14.3.1 Sanofi-Aventis Company Details
-
14.3.2 Sanofi-Aventis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi-Aventis RNA Drugs Product and Service
-
14.4 Tekmira
-
14.4.1 Tekmira Company Details
-
14.4.2 Tekmira RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Tekmira RNA Drugs Product and Service
-
14.5 Calimmune Inc
-
14.5.1 Calimmune Inc Company Details
-
14.5.2 Calimmune Inc RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Calimmune Inc RNA Drugs Product and Service
-
14.6 Gradalis
-
14.6.1 Gradalis Company Details
-
14.6.2 Gradalis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Gradalis RNA Drugs Product and Service
-
14.7 Arrowhead Pharmaceuticals
-
14.7.1 Arrowhead Pharmaceuticals Company Details
-
14.7.2 Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Arrowhead Pharmaceuticals RNA Drugs Product and Service
-
14.8 Silenseed
-
14.8.1 Silenseed Company Details
-
14.8.2 Silenseed RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Silenseed RNA Drugs Product and Service
-
14.9 Silence Therapeutics
-
14.9.1 Silence Therapeutics Company Details
-
14.9.2 Silence Therapeutics RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Silence Therapeutics RNA Drugs Product and Service
-
14.10 Senesco
-
14.10.1 Senesco Company Details
-
14.10.2 Senesco RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Senesco RNA Drugs Product and Service
-
14.11 Roche
-
14.11.1 Roche Company Details
-
14.11.2 Roche RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Roche RNA Drugs Product and Service
-
14.12 RXi
-
14.12.1 RXi Company Details
-
14.12.2 RXi RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 RXi RNA Drugs Product and Service
-
14.13 Alnylam Pharmaceuticals
-
14.13.1 Alnylam Pharmaceuticals Company Details
-
14.13.2 Alnylam Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Alnylam Pharmaceuticals RNA Drugs Product and Service
-
14.14 Dicerna
-
14.14.1 Dicerna Company Details
-
14.14.2 Dicerna RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Dicerna RNA Drugs Product and Service
-
14.15 Quark
-
14.15.1 Quark Company Details
-
14.15.2 Quark RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Quark RNA Drugs Product and Service
-
14.16 Pfizer
-
14.16.1 Pfizer Company Details
-
14.16.2 Pfizer RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Pfizer RNA Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of RNA Drugs
-
Figure RNA Drugs Picture
-
Table Global RNA Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global RNA Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global RNA Drugs Consumption by Country (2017-2022)
-
Figure United States RNA Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure China RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure India RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea RNA Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global RNA Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea RNA Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global siRNA Consumption and Growth Rate (2017-2022)
-
Figure Global ASO Consumption and Growth Rate (2017-2022)
-
Figure Global miRNA Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleic Acid Aptamers Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Tuberculosis Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global siRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ASO Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global miRNA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nucleic Acid Aptamers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tuberculosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global RNA Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global RNA Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories RNA Drugs Product and Service
-
Table Benitec Biopharma (Foundation Year, Company Profile and etc.)
-
Table Benitec Biopharma RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benitec Biopharma RNA Drugs Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis RNA Drugs Product and Service
-
Table Tekmira (Foundation Year, Company Profile and etc.)
-
Table Tekmira RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tekmira RNA Drugs Product and Service
-
Table Calimmune Inc (Foundation Year, Company Profile and etc.)
-
Table Calimmune Inc RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Calimmune Inc RNA Drugs Product and Service
-
Table Gradalis (Foundation Year, Company Profile and etc.)
-
Table Gradalis RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis RNA Drugs Product and Service
-
Table Arrowhead Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arrowhead Pharmaceuticals RNA Drugs Product and Service
-
Table Silenseed (Foundation Year, Company Profile and etc.)
-
Table Silenseed RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silenseed RNA Drugs Product and Service
-
Table Silence Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Silence Therapeutics RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Silence Therapeutics RNA Drugs Product and Service
-
Table Senesco (Foundation Year, Company Profile and etc.)
-
Table Senesco RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Senesco RNA Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche RNA Drugs Product and Service
-
Table RXi (Foundation Year, Company Profile and etc.)
-
Table RXi RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table RXi RNA Drugs Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals RNA Drugs Product and Service
-
Table Dicerna (Foundation Year, Company Profile and etc.)
-
Table Dicerna RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dicerna RNA Drugs Product and Service
-
Table Quark (Foundation Year, Company Profile and etc.)
-
Table Quark RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quark RNA Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer RNA Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer RNA Drugs Product and Service
-